Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients

K. Patel; T. A. Gooley; N. Bailey; M. Bailey; L. Hegerova; A. Batchelder; H. Holdread; V. Dunleavy; T. Downey; J. Frisvold; S. Megrath; K. Pagarigan; J. Szeto; J. Rueda; A. Islam; C. Maree; S. Nyatsatsang; S. E. Bork; A. Lipke; D. S. O’Mahony; T. Wagner; J. Pulido; J. Mignone; S. Youssef; M. Hartman; J. D. Goldman; J. M. Pagel

doi:10.1111/joim.13163

Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients

K. Patel, T. A. Gooley, N. Bailey, M. Bailey, L. Hegerova, A. Batchelder, H. Holdread, V. Dunleavy, T. Downey, J. Frisvold, S. Megrath, K. Pagarigan, J. Szeto, J. Rueda, A. Islam, C. Maree, S. Nyatsatsang, S. E. Bork, A. Lipke, D. S. O’MahonyT. Wagner, J. Pulido, J. Mignone, S. Youssef, M. Hartman, J. D. Goldman, J. M. Pagel

Research output: Contribution to journal › Letter › peer-review

22 Scopus citations

Original language	English
Pages (from-to)	430-433
Number of pages	4
Journal	Journal of Internal Medicine
Volume	289
Issue number	3
DOIs	https://doi.org/10.1111/joim.13163
State	Published - Mar 2021

Access to Document

10.1111/joim.13163

Cite this

Patel, K., Gooley, T. A., Bailey, N., Bailey, M., Hegerova, L., Batchelder, A., Holdread, H., Dunleavy, V., Downey, T., Frisvold, J., Megrath, S., Pagarigan, K., Szeto, J., Rueda, J., Islam, A., Maree, C., Nyatsatsang, S., Bork, S. E., Lipke, A., ... Pagel, J. M. (2021). Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients. Journal of Internal Medicine, 289(3), 430-433. https://doi.org/10.1111/joim.13163

@article{83f6dc5341d14e3f842c20977efd26fc,

title = "Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients",

author = "K. Patel and Gooley, {T. A.} and N. Bailey and M. Bailey and L. Hegerova and A. Batchelder and H. Holdread and V. Dunleavy and T. Downey and J. Frisvold and S. Megrath and K. Pagarigan and J. Szeto and J. Rueda and A. Islam and C. Maree and S. Nyatsatsang and Bork, {S. E.} and A. Lipke and O{\textquoteright}Mahony, {D. S.} and T. Wagner and J. Pulido and J. Mignone and S. Youssef and M. Hartman and Goldman, {J. D.} and Pagel, {J. M.}",

year = "2021",

month = mar,

doi = "10.1111/joim.13163",

language = "English",

volume = "289",

pages = "430--433",

journal = "Journal of Internal Medicine",

issn = "0954-6820",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

Patel, K, Gooley, TA, Bailey, N, Bailey, M, Hegerova, L, Batchelder, A, Holdread, H, Dunleavy, V, Downey, T, Frisvold, J, Megrath, S, Pagarigan, K, Szeto, J, Rueda, J, Islam, A, Maree, C, Nyatsatsang, S, Bork, SE, Lipke, A, O’Mahony, DS, Wagner, T, Pulido, J , Mignone, J, Youssef, S, Hartman, M, Goldman, JD & Pagel, JM 2021, 'Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients', Journal of Internal Medicine, vol. 289, no. 3, pp. 430-433. https://doi.org/10.1111/joim.13163

TY - JOUR

T1 - Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients

AU - Patel, K.

AU - Gooley, T. A.

AU - Bailey, N.

AU - Bailey, M.

AU - Hegerova, L.

AU - Batchelder, A.

AU - Holdread, H.

AU - Dunleavy, V.

AU - Downey, T.

AU - Frisvold, J.

AU - Megrath, S.

AU - Pagarigan, K.

AU - Szeto, J.

AU - Rueda, J.

AU - Islam, A.

AU - Maree, C.

AU - Nyatsatsang, S.

AU - Bork, S. E.

AU - Lipke, A.

AU - O’Mahony, D. S.

AU - Wagner, T.

AU - Pulido, J.

AU - Mignone, J.

AU - Youssef, S.

AU - Hartman, M.

AU - Goldman, J. D.

AU - Pagel, J. M.

PY - 2021/3

Y1 - 2021/3

UR - http://www.scopus.com/inward/record.url?scp=85090946377&partnerID=8YFLogxK

U2 - 10.1111/joim.13163

DO - 10.1111/joim.13163

M3 - Letter

C2 - 32745348

AN - SCOPUS:85090946377

SN - 0954-6820

VL - 289

SP - 430

EP - 433

JO - Journal of Internal Medicine

JF - Journal of Internal Medicine

IS - 3

ER -

Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients

Access to Document

Other files and links

Cite this